Skip to main content
OpenTrials
Completed

NCT Number: NCT02471157

Hormonal Predictors of Oncologic Surgery

An observational trial to determine whether preoperative hormonal status predicts outcomes of oncologic surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypogonadism Endocrine System Diseases Gonadal Disorders

Age range

40 year and older

Sex eligibility

Male

Study type

Observational

Primary location

Weill Cornell Medical College

New York, 10065, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Undergoing above surgery for cancer

Exclusion criteria

  • Started hormonal replacement in past two months

Treatment and study plan

observation

Other

Primary outcomes

  1. Length of Stay

    Time frame: 6 days, on average

    Length of post-operative stay

  2. Complication rate, post-operative

    Time frame: 6 days, on average

    Complication rate during initial postoperative period

  3. Complication rate, 30 day

    Time frame: 30 days

    Complication rate during the initial 30 days after surgery

  4. Complication rate, 90 days

    Time frame: 90 days

    Complication rate during the initial 90 days after surgery

Sponsors and collaborators

Lead sponsor

Weill Medical College of Cornell University

Other

Registry information

Official study title

The Association of Hypogonadism and Post-operative Outcomes of Oncologic Surgery

Acronym: HPOS

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Jun 15, 2015
Registry last updated
Jan 25, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.